eCite Digital Repository

Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

Citation

Khalafallah, AA and Brain, T, Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia, Mediterranean Journal of Hematology and Infectious Diseases, 2, (2) EJ ISSN 2035-3006 (2009) [Letter or Note in Journal]

DOI: doi:10.4084/MJHID.2010.012

Item Details

Item Type:Letter or Note in Journal
Research Division:Medical and Health Sciences
Research Group:Cardiorespiratory Medicine and Haematology
Research Field:Haematology
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Blood Disorders
Author:Khalafallah, AA (Professor Alhossain Khalafallah)
ID Code:63934
Year Published:2009
Deposited By:Health Sciences A
Deposited On:2010-06-09
Last Modified:2011-09-14
Downloads:0

Repository Staff Only: item control page